The Associated Press
SHAREHOLDERS SETTLE: Johnson & Johnson stockholders, trying to restore high standards, have reached a tentative settlement in their lawsuit against J&J's board and top executives for alleging letting serious legal and manufacturing problems continue for years.
LAUNDRY LIST: Lapses include paying kickbacks to boost product sales, marketing drugs for unapproved uses and repeatedly recalling prescription and nonprescription drugs and medical devices due to manufacturing deficiencies, including wrong levels of active ingredients and metal shards in liquid medicines.
COMPANY RESPONSE: J&J denies the plaintiffs' claims, saying it's settling to benefit J&J and its shareholders and to end distracting, expensive litigation.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts